Amirhossein Heidari, MD

Medical Doctor @danaenergy, Research assistant @TehUofMed, Athlete

[Amirhossein Heidari, MD @amirhhmd_]

Pleased to receive a @WileyGlobal Reviewer Certificate for reviewing 20 manuscripts for Clinical Case Reports in 2025.
Proud to contribute to rigorous peer review and the advancement of high-quality scientific publishing.

#MedTwitter #Wiley #PeerReview #AcademicPublishing

[Amirhossein Heidari, MD @amirhhmd_]

These findings highlight the potential role of Nd in the management of venous lake lesions and support the need for larger randomized studies to further validate these results./4

Acces link:
https://t.co/gDRCfpAn0v

#Dermatology #LaserMedicine #NdYAG #PDL #VenousLake

[Amirhossein Heidari, MD @amirhhmd_]

I am pleased to share our recently published original research article in Lasers in Medical Science, @SpringerNature Publishing Group, entitled
“Comparative Evaluation of Long-Pulsed Nd and Pulsed Dye Lasers in the Treatment of Venous Lake Lesions: A Prospective Clinical Study”/1

[Amirhossein Heidari, MD @amirhhmd_]

In this prospective clinical study, we compared long-pulsed Nd: YAG and PDL for the treatment of venous lake lesions.
Our findings suggest that Nd: YAG may offer greater clinical improvement, particularly in lesion color, while both treatment modalities were well tolerated./2

[Amirhossein Heidari, MD @amirhhmd_]

@SpringerNature Publishing Group (IF:2.7).
Access link:
https://t.co/POjCd09vlT

#pustularpsoriasis #generalizedpustularpsoriasis #palmoplantarpustulosis #JAKinhibitors #Tykinhibitors

[Amirhossein Heidari, MD @amirhhmd_]

Please checkout our recent published systematic review entitled "Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review" in prestigious journal Immunologic Research,/1

[Amirhossein Heidari, MD @amirhhmd_]

Access link:
https://t.co/mKL6aVA77S

[Amirhossein Heidari, MD @amirhhmd_]

Pleased to share our latest publication in Cardiology Research and Practice, @WileyGlobal (CS:3.5)
Using data from 4,478 women enrolled in the Tehran Cohort Study (TeCS), we examined the burden and determinants of coronary artery disease (CAD) among women in Tehran./1

[Amirhossein Heidari, MD @amirhhmd_]

These findings underscore the considerable burden of CAD among women and reinforce the need for early risk-factor identification and targeted cardiovascular prevention.

#MedTwitter #Cardiology #WomensHealth #CoronaryArteryDisease #TeCS

[Amirhossein Heidari, MD @amirhhmd_]

in the differential diagnosis of pediatric abdominopelvic masses./2
Access link: https://t.co/xyM1ry6yi6

#MedTwitter #InflammatoryMyofibroblasticTumor #PediatricOncology #PediatricSurgery #SurgicalOncology #CaseReport

[Amirhossein Heidari, MD @amirhhmd_]

Our case report has been published in the International Journal of Surgery Case Reports
We describe an unusual abdominopelvic inflammatory myofibroblastic tumor (IMT) in an adolescent male, emphasizing the diagnostic overlap with malignancy and the importance of considering IMT/1

[Amirhossein Heidari, MD @amirhhmd_]

Access link:
https://t.co/EnBk9PtTVj

#MedTwitter #RGRN305 #Hsp90 #Hsp90Inhibitor #Dermatology #InflammatorySkinDisease #Psoriasis #HidradenitisSuppurativa #Immunology #AutoimmuneDisease #DrugDevelopment #TranslationalMedicine

[Amirhossein Heidari, MD @amirhhmd_]

Excited to share our latest review published in Inflammopharmacology, @SpringerNature!
As the corresponding author, I’m pleased to present our comprehensive review on RGRN-305,a novel Hsp90 inhibitor, highlighting its therapeutic potential in inflammatory dermatologic diseases/1

[Amirhossein Heidari, MD @amirhhmd_]

Current evidence suggests promising anti-inflammatory and immunomodulatory effects in psoriasis, hidradenitis suppurativa, and other immune-mediated skin disorders, while emphasizing the need for larger randomized clinical trials.
Congratulations to all my co-authors!/2

[Amirhossein Heidari, MD @amirhhmd_]

Congratulations to all co-authors and collaborators.
Access link:
https://t.co/Vhih9wQEGj
#medtwitter #AndrogeneticAlopecia #HairLoss #Alopecia #HairRegeneration #HairResearch #RegenerativeMedicine #ConditionedMedium #Dermatology

[Amirhossein Heidari, MD @amirhhmd_]

Excited to see our work published in Dermatologic Therapy, @WileyGlobal.

This pilot clinical trial evaluated Human Foreskin Fibroblast–Conditioned Medium (HFF-CM) as a regenerative treatment for androgenetic alopecia, with encouraging results for hair growth and scalp health./1

[Amirhossein Heidari, MD @amirhhmd_]

Access link:
https://t.co/aFm431GJ0a

#MedTwitter #Osteoporosis #Denosumab #Biosimilars #Systematicreview #Clinicalقesearch

[Amirhossein Heidari, MD @amirhhmd_]

I am pleased to share the publication of our systematic review entitled“Efficacy and safety of denosumab biosimilars in the treatment of postmenopausal osteoporosis: A systematic review of randomized clinical trials” published in Clinical and Experimental Medicine (Q1, IF: 3.6)/1

[Amirhossein Heidari, MD @amirhhmd_]

Our analysis of 11 RCTs demonstrated that denosumab biosimilars have comparable efficacy, safety, and immunogenicity to Prolia®, supporting their role as cost-effective alternatives for postmenopausal osteoporosis management./2